publication venue for Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.. 14:73-80. 2008 A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients.. 12:309-320. 2006 Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial.. 9:585-591. 2003
